These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21056992)

  • 21. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.
    Wei X; Xu H; Kufe D
    Cancer Cell; 2005 Feb; 7(2):167-78. PubMed ID: 15710329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SEI family of nuclear factors regulates p53-dependent transcriptional activation.
    Watanabe-Fukunaga R; Iida S; Shimizu Y; Nagata S; Fukunaga R
    Genes Cells; 2005 Aug; 10(8):851-60. PubMed ID: 16098148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
    Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
    Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells.
    Mizuarai S; Yamanaka K; Kotani H
    Cancer Res; 2006 Jun; 66(12):6319-26. PubMed ID: 16778209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress.
    Tang X; Milyavsky M; Goldfinger N; Rotter V
    Oncogene; 2007 Nov; 26(52):7302-12. PubMed ID: 17533371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
    Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
    Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AP2alpha alters the transcriptional activity and stability of p53.
    Stabach PR; Thiyagarajan MM; Woodfield GW; Weigel RJ
    Oncogene; 2006 Apr; 25(15):2148-59. PubMed ID: 16288208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo analyses of UV-irradiation-induced p53 promoter binding using a novel quantitative real-time PCR assay.
    Potratz JC; Mlody B; Berdel WE; Serve H; Müller-Tidow C
    Int J Oncol; 2005 Feb; 26(2):493-8. PubMed ID: 15645135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-specific MAGE proteins as regulators of p53 function.
    Ladelfa MF; Peche LY; Toledo MF; Laiseca JE; Schneider C; Monte M
    Cancer Lett; 2012 Dec; 325(1):11-7. PubMed ID: 22664239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells.
    Tsuda Y; Tanikawa C; Miyamoto T; Hirata M; Yodsurang V; Zhang YZ; Imoto S; Yamaguchi R; Miyano S; Takayanagi H; Kawano H; Nakagawa H; Tanaka S; Matsuda K
    Sci Rep; 2017 Sep; 7(1):10739. PubMed ID: 28878391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines.
    Yang B; O'Herrin SM; Wu J; Reagan-Shaw S; Ma Y; Bhat KM; Gravekamp C; Setaluri V; Peters N; Hoffmann FM; Peng H; Ivanov AV; Simpson AJ; Longley BJ
    Cancer Res; 2007 Oct; 67(20):9954-62. PubMed ID: 17942928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cabin1 restrains p53 activity on chromatin.
    Jang H; Choi SY; Cho EJ; Youn HD
    Nat Struct Mol Biol; 2009 Sep; 16(9):910-5. PubMed ID: 19668210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of SULF2 as a novel transcriptional target of p53 by use of integrated genomic analyses.
    Chau BN; Diaz RL; Saunders MA; Cheng C; Chang AN; Warrener P; Bradshaw J; Linsley PS; Cleary MA
    Cancer Res; 2009 Feb; 69(4):1368-74. PubMed ID: 19190338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 binding sites in normal and cancer cells are characterized by distinct chromatin context.
    Bao F; LoVerso PR; Fisk JN; Zhurkin VB; Cui F
    Cell Cycle; 2017; 16(21):2073-2085. PubMed ID: 28820292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma antigen A12 regulates cell cycle via tumor suppressor p21 expression.
    Yanagi T; Nagai K; Shimizu H; Matsuzawa SI
    Oncotarget; 2017 Sep; 8(40):68448-68459. PubMed ID: 28978129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells.
    Hsiao BY; Chen CC; Hsieh PC; Chang TK; Yeh YC; Wu YC; Hsu HS; Wang FF; Chou TY
    J Mol Med (Berl); 2011 May; 89(5):481-92. PubMed ID: 21221513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo.
    Shimizu T; Sugihara E; Takeshima H; Nobusue H; Yamaguchi R; Yamaguchi-Iwai S; Fukuchi Y; Ushijima T; Muto A; Saya H
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of universal and cell-type specific p53 DNA binding.
    Hafner A; Kublo L; Tsabar M; Lahav G; Stewart-Ornstein J
    BMC Mol Cell Biol; 2020 Feb; 21(1):5. PubMed ID: 32070277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer: Mutant p53 and chromatin regulation.
    Prives C; Lowe SW
    Nature; 2015 Sep; 525(7568):199-200. PubMed ID: 26331537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.